Unmet Medical Need

Surgery is the most common first-line treatment for lung cancer
Recurrence is common and lethal
No current therapy prevents recurrence

What Leading Thoracic Surgeons Say

“There is a great need for this drug delivery device, especially in the patient who
cannot tolerate a lobectomy who must have segmentectomy or wedge resection. This new drug delivery device is a great idea that will be embraced by surgeons…”

‐ Division of thoracic surgery, Leading metropolitan academic medical center

“This new drug delivery device is very unique. There is no commercially
available product similar to this on the market … There should be signiﬁcant
room for using this device in lung cancer surgery.” Thoracic Surgeon regional
medical center

‐Thoracic surgeon regional medical center